{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:28:20Z","timestamp":1791808100388,"version":"4.3.4"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"NIMHD","doi-asserted-by":"publisher","award":["1P50MD017356-01"],"award-info":[{"award-number":["1P50MD017356-01"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>As disease-modifying therapies for Alzheimer's disease become available, ensuring equitable access to timely and accurate diagnosis of cognitive impairment is critical. This article conceptualizes \u201cdementia diagnostic deserts,\u201d defined as geographic areas where rurality, primary care professional shortages, and high social deprivation converge to exacerbate access to the diagnostic continuum, from initial screening and comprehensive evaluation to the appropriate referral for specialist-based diagnostic confirmation. Using a multidimensional framework, we identify \u201cTriple Disadvantage Zones\u201d where these barriers intersect most severely, leading to diagnostic errors, characterized by failure to differentiate subjective complaints from objective impairment. This diagnostic failure produces 2 distinct forms of diagnostic inequity: delayed diagnosis for those with true pathology, and inappropriate over-testing for those who do not meet clinical criteria. Nurse practitioners and physician assistants are frontline providers in these underserved regions but face significant training gaps and practice-level infrastructure barriers. Addressing these disparities requires a multidimensional policy approach that targets the convergence of geographic, workforce, and socioeconomic barriers rather than rurality alone. We propose a coordinated policy agenda focused on comprehensive clinical triage training, appropriate reimbursement for clinician time, financial assistance for diagnostic testing, and investments in practice-level capacity for the entire diagnostic pathway and subsequent care.<\/jats:p>","DOI":"10.1093\/haschl\/qxag109","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:48:01Z","timestamp":1779450481000},"source":"Crossref","is-referenced-by-count":1,"title":["Dementia diagnostic deserts: workforce and geographic inequities in the diagnostic pathway for cognitive impairment"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4044-9609","authenticated-orcid":false,"given":"Zhijing","family":"Xu","sequence":"first","affiliation":[{"name":"Rory Meyers College of Nursing, New York University , New York, NY 10010 ,","place":["United States"]},{"name":"School of Nursing and Department of Family Science and Human Development, College for Community Health, Montclair State University , Montclair, NJ 07043 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xue","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Rochester , Rochester, NY 14642 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8400-1398","authenticated-orcid":false,"given":"Yaguang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Rory Meyers College of Nursing, New York University , New York, NY 10010 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6891-244X","authenticated-orcid":false,"given":"Bei","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Arts and Sciences, New York University Shanghai , Shanghai 200126 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"2","key":"2026052706564319500_qxag109-B1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/joim.13244","article-title":"Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis","volume":"290","author":"Liss","year":"2021","journal-title":"J Intern Med"},{"issue":"3","key":"2026052706564319500_qxag109-B2","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70156","article-title":"Real-world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee-for-service beneficiaries","volume":"17","author":"Yan","year":"2025","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"2026052706564319500_qxag109-B3","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14201","article-title":"Clinical use of biomarkers in the era of Alzheimer's disease treatments","volume":"21","author":"VandeVrede","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2026052706564319500_qxag109-B4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","article-title":"Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"2026052706564319500_qxag109-B5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3233\/JAD-150692","article-title":"Timely diagnosis for Alzheimer's disease: a literature review on benefits and challenges","volume":"49","author":"Dubois","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"2026052706564319500_qxag109-B6","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1177\/13872877251322978","article-title":"Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: a multinational, real-world survey","volume":"104","author":"Vasileva-Metodiev","year":"2025","journal-title":"J Alzheimers Dis"},{"issue":"18","key":"2026052706564319500_qxag109-B7","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","article-title":"Blood-based biomarkers for Alzheimer's disease: current state and future use in a transformed global healthcare landscape","volume":"111","author":"Hampel","year":"2023","journal-title":"Neuron"},{"issue":"10","key":"2026052706564319500_qxag109-B8","doi-asserted-by":"publisher","first-page":"100630","DOI":"10.1016\/j.lanhl.2024.07.013","article-title":"Challenges in the practical implementation of blood biomarkers for Alzheimer's disease","volume":"5","author":"Sch\u00f6ll","year":"2024","journal-title":"Lancet Healthy Longev"},{"issue":"3","key":"2026052706564319500_qxag109-B9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1212\/CON.0000000000001088","article-title":"Health disparities in dementia","volume":"28","author":"Balls-Berry","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"2026052706564319500_qxag109-B10","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14203","article-title":"Paving the way for Alzheimer's disease blood-based biomarkers in primary care","volume":"21","author":"Erickson","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"Supplement_1","key":"2026052706564319500_qxag109-B11","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1093\/geront\/gnaf221","article-title":"Advancing early and equitable detection of dementia: key learnings\/challenges, recent innovations, and future directions","volume":"65","author":"Chodosh","year":"2025","journal-title":"Gerontologist"},{"issue":"11","key":"2026052706564319500_qxag109-B12","doi-asserted-by":"publisher","first-page":"8216","DOI":"10.1002\/alz.14184","article-title":"Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease","volume":"20","author":"Mielke","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"7","key":"2026052706564319500_qxag109-B13","doi-asserted-by":"publisher","first-page":"e13809","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","author":"Alzheimer's Association","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2026052706564319500_qxag109-B14","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14528","article-title":"Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease","volume":"21","author":"Leuzy","year":"2025","journal-title":"Alzheimers Dement"},{"key":"2026052706564319500_qxag109-B15","doi-asserted-by":"publisher","DOI":"10.1177\/21501319251394537","article-title":"Feasibility of an Alzheimer's disease care pathway: findings from an educational pilot in 2 healthcare systems","volume":"16","author":"Bozoki","year":"2025","journal-title":"J Prim Care Community Health"},{"issue":"4","key":"2026052706564319500_qxag109-B16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/19475683.2020.1833365","article-title":"Examining spatial accessibility to COVID-19 testing sites in Florida","volume":"26","author":"Tao","year":"2020","journal-title":"Ann GIS"},{"issue":"5","key":"2026052706564319500_qxag109-B17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.jadohealth.2024.01.011","article-title":"HIV testing deserts and vulnerability among adolescents and young adults in Tampa Bay, Florida","volume":"74","author":"Vilidnitsky","year":"2024","journal-title":"J Adolesc Health"},{"key":"2026052706564319500_qxag109-B18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.annepidem.2021.03.009","article-title":"Coronavirus testing disparities associated with community level deprivation, racial inequalities, and food insecurity in West Virginia","volume":"59","author":"Hendricks","year":"2021","journal-title":"Ann Epidemiol"},{"issue":"3","key":"2026052706564319500_qxag109-B19","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3390\/ijerph19031749","article-title":"Changes in access to health services during the COVID-19 pandemic: a scoping review","volume":"19","author":"Pujolar","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026052706564319500_qxag109-B20","doi-asserted-by":"publisher","first-page":"E27","DOI":"10.5888\/pcd22.250202","article-title":"Rural health disparities: contemporary solutions for persistent rural public health challenges","volume":"22","author":"Matthews","year":"2025","journal-title":"Prev Chronic Dis"},{"key":"2026052706564319500_qxag109-B21","doi-asserted-by":"publisher","first-page":"894370","DOI":"10.3389\/fpsyt.2022.894370","article-title":"Social vulnerability and mental health inequalities in the \u201csyndemic\u201d: call for action","volume":"13","author":"Mezzina","year":"2022","journal-title":"Front Psychiatry"},{"issue":"1","key":"2026052706564319500_qxag109-B22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12913-022-07829-2","article-title":"A qualitative study of rural healthcare providers\u2019 views of social, cultural, and programmatic barriers to healthcare access","volume":"22","author":"Coombs","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"2026052706564319500_qxag109-B23","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/alz.12509","article-title":"Black and white individuals differ in dementia prevalence, risk factors, and symptomatic presentation","volume":"18","author":"Lennon","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"12","key":"2026052706564319500_qxag109-B24","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"2026052706564319500_qxag109-B25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s40478-025-02064-2","article-title":"Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort","volume":"13","author":"Bali","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"2026052706564319500_qxag109-B26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s43587-023-00375-4","article-title":"CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease","volume":"3","author":"Barth\u00e9lemy","year":"2023","journal-title":"Nat Aging"},{"issue":"2","key":"2026052706564319500_qxag109-B27","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12465","article-title":"Alzheimer's disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimers Dement (N Y)"},{"issue":"9","key":"2026052706564319500_qxag109-B28","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.3390\/ijms23094962","article-title":"Biomarkers for Alzheimer's disease in the current state: a narrative review","volume":"23","author":"Gunes","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2026052706564319500_qxag109-B29","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.4103\/NRR.NRR-D-23-01945","article-title":"Are we close to using Alzheimer blood biomarkers in clinical practice?","volume":"19","author":"Imbimbo","year":"2024","journal-title":"Neural Regen Res"},{"issue":"7","key":"2026052706564319500_qxag109-B30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamainternmed.2025.0976","article-title":"The limited role of Alzheimer disease blood-based biomarkers in primary care","volume":"185","author":"Widera","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2026052706564319500_qxag109-B31","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70986","article-title":"Early Alzheimer's diagnosis: U.S. primary care physicians and use of blood biomarkers","volume":"22","author":"Burns","year":"2026","journal-title":"Alzheimers Dement"},{"key":"2026052706564319500_qxag109-B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00296","article-title":"Research lumbar punctures among African Americans and Caucasians: perception predicts experience","volume":"8","author":"Howell","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"2026052706564319500_qxag109-B33","first-page":"200","article-title":"The role of health policy in improving health outcomes and health equity","volume":"134","author":"Maddox","year":"2024","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"2026052706564319500_qxag109-B34","author":"Gooptu"},{"key":"2026052706564319500_qxag109-B35","author":"Health Resources and Services Administration"},{"issue":"2","key":"2026052706564319500_qxag109-B36","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxaf006","article-title":"An unclear partnership: key questions about physician and advanced practice provider collaboration in primary care","volume":"3","author":"Martin","year":"2025","journal-title":"Health Aff Sch"},{"issue":"11","key":"2026052706564319500_qxag109-B37","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.44659","article-title":"Supply and geographic distribution of geriatric physicians and geriatric nurse practitioners","volume":"7","author":"Xue","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"6","key":"2026052706564319500_qxag109-B38","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1377\/hlthaff.2017.1158","article-title":"Rural and nonrural primary care physician practices increasingly rely on nurse practitioners","volume":"37","author":"Barnes","year":"2018","journal-title":"Health Aff (Millwood)"},{"key":"2026052706564319500_qxag109-B39","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.gerinurse.2024.11.020","article-title":"Role of nurse practitioners in comprehensive Alzheimer's disease care: barriers and opportunities for timely diagnosis","volume":"61","author":"Clevenger","year":"2025","journal-title":"Geriatr Nurs"},{"issue":"5","key":"2026052706564319500_qxag109-B40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/10775587241251868","article-title":"Strengthening primary care workforce capacity in dementia diagnosis and care: a qualitative study of project Alzheimer's Disease-ECHO","volume":"81","author":"Sideman","year":"2024","journal-title":"Med Care Res Rev"},{"issue":"3","key":"2026052706564319500_qxag109-B41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.14283\/jpad.2020.21","article-title":"Early detection of mild cognitive impairment (MCI) in primary care","volume":"7","author":"Sabbagh","year":"2020","journal-title":"J Prev Alzheimers Dis"},{"issue":"9","key":"2026052706564319500_qxag109-B42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.36030","article-title":"Primary care practitioner perspectives on the role of primary care in dementia diagnosis and care","volume":"6","author":"Sideman","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026052706564319500_qxag109-B43","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251326233","article-title":"Addressing health service equity through telehealth: a systematic review of reviews","volume":"11","author":"Wang","year":"2025","journal-title":"Digit Health"},{"issue":"11","key":"2026052706564319500_qxag109-B44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"2026052706564319500_qxag109-B45","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jagp.2021.01.135","article-title":"The growing primary care nurse practitioner workforce: a solution for the aging population living with dementia","volume":"29","author":"Poghosyan","year":"2021","journal-title":"Am J Geriatr Psychiatry"},{"key":"2026052706564319500_qxag109-B46","author":"American Association of Nurse Practitioners"},{"issue":"2","key":"2026052706564319500_qxag109-B47","doi-asserted-by":"publisher","first-page":"e2458839","DOI":"10.1001\/jamanetworkopen.2024.58839","article-title":"Demographics and practice attributes of physician assistants in neurology","volume":"8","author":"Bruza-Augatis","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026052706564319500_qxag109-B48","author":"Health Resources and Services Administration"},{"issue":"1","key":"2026052706564319500_qxag109-B49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12875-025-02855-5","article-title":"Dementia care management in primary care practices: a descriptive study among nurse practitioners","volume":"26","author":"Poghosyan","year":"2025","journal-title":"BMC Prim Care"},{"issue":"8","key":"2026052706564319500_qxag109-B50","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41582-024-00989-1","article-title":"Alzheimer disease blood biomarkers: considerations for population-level use","volume":"20","author":"Mielke","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"2026052706564319500_qxag109-B51","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/fampra\/cmae043","article-title":"Confidence in diagnosing and managing care for cognitive impairment in primary care: a survey comparing barriers by primary care clinician type","volume":"41","author":"JaKa","year":"2024","journal-title":"Fam Pract"},{"issue":"9","key":"2026052706564319500_qxag109-B52","doi-asserted-by":"publisher","first-page":"100310","DOI":"10.1016\/j.tjpad.2025.100310","article-title":"Disclosure of Alzheimer's disease blood-based biomarker results in a primary care setting: opportunities and challenges","volume":"12","author":"Bolton","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"2026052706564319500_qxag109-B53","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol"},{"key":"2026052706564319500_qxag109-B54","author":"Siegel"}],"container-title":["Health Affairs Scholar"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article-pdf\/4\/5\/qxag109\/68409436\/qxag109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article-pdf\/4\/5\/qxag109\/68409436\/qxag109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:56:48Z","timestamp":1779879408000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article\/doi\/10.1093\/haschl\/qxag109\/8695893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/haschl\/qxag109","relation":{},"ISSN":["2976-5390"],"issn-type":[{"value":"2976-5390","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,5]]},"article-number":"qxag109"}}